Patent directory · USPTO A61K / A61P
Patents matching “United States Government as represented by the Department of Veterans Affairs”
144 pharma patents match "United States Government as represented by the Department of Veterans Affairs" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 144 pharmaceutical patents matching "United States Government as represented by the Department of Veterans Affairs" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10675283
Compositions and methods for white to beige adipogenesis
granted -
US 10668087
Methods for inhibiting muscle atrophy
granted -
US 10626399
Methods of treating cognitive symptoms of an aging-associated impairment by modulating C-C chemokine receptor type 3 (CCR3)
granted -
US 10576091
Tomatidine, analogs thereof, compositions comprising same, and uses for same
granted -
US 10555961
Materials and methods for treating bacterial infections using C-1 gentamicin
granted -
US 10548860
HIF-1 modulator paint formulation and uses thereof
granted -
US 10537577
Compounds and compositions for ossification and methods related thereto
granted -
US 10531654
Methods and compositions for vein harvest and autografting
granted -
US 10525101
Methods of treating inflammatory or autoimmune disorders with compounds that bind macrophage migration inhibitory factor
granted -
US 10513494
Methods, compounds, and compositions for anesthesia
granted -
US 10487076
Compositions and methods for treating diseases and conditions
granted -
US 10478435
Use of CRAC channel inhibitors for the treatment of stroke and traumatic brain injury
granted -
US 10456404
Targeting cGMP-related phosphodiesterases to reduce cyst formation in cystic kidney disease, and related materials and methods
granted -
US 10450371
Monoclonal antibody and antigens for diagnosing and treating lung disease and injury
granted -
US 10434188
Hyaluronic acid binding domain-growth factor fusion protein cDNAs and fusion proteins for cartilage matrix preservation and repair
granted -
US 10307423
FBXO3 inhibitors
granted -
US 10286054
Attenuated EHEC and clostridial toxins TcdA and TcdB based vaccine for Clostridium difficil associated disease (CDAD)
granted -
US 9962379
Inhibitors of the FKBP51 protein from a high-throughput drug screen and methods of use
granted -
US 9506922
Methods for producing an immune response to tuberculosis
granted -
US 9295754
Noggin inhibitory compositions for ossification and methods related thereto
granted -
US 9243051
Monomeric recombinant MHC molecules useful for manipulation of antigen-specific T-cells
granted -
US 9155801
Amino acid sequences which enhance peptide conjugate solubility
granted -
US 8685404
Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric impairment induced by substance addiction
granted -
US 7741113
Cell-specific molecule and method for importing DNA into osteoblast nuclei
granted